Microbial Enzyme Impact on Postprandial Nutrient Levels and Gastrointestinal Symptoms in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 18, 2022

Primary Completion Date

August 25, 2023

Study Completion Date

August 25, 2023

Conditions
Digestive HealthGastrointestinal Health
Interventions
DIETARY_SUPPLEMENT

Placebo + Meal

Subjects will be directed to consume 1 placebo capsule containing maltodextrin, twice daily, for 21 days. Subjects will be directed to consume the capsules with their two largest meals, in between the third and second bites of food. During the MMTT, a placebo capsule will be consumed with a standardized test meal containing chicken, peas, potatoes, and butter.

DIETARY_SUPPLEMENT

BC-006 + Meal

Subjects will be directed to consume 1 capsule containing BC-006, twice daily, for 21 days. Subjects will be directed to consume the capsules with their two largest meals, in between the third and second bites of food. During the MMTT, a BC-006 capsule will be consumed with a standardized test meal containing chicken, peas, potatoes, and butter.

Trial Locations (1)

61801

Freer Hall, Urbana

All Listed Sponsors
collaborator

BIO-CAT, Inc.

INDUSTRY

lead

University of Illinois at Urbana-Champaign

OTHER